Herpes Zoster in a Patient With Ulcerative Colitis After Vedolizumab Initiation-Causal Link or Only Temporal Coincidence?

Inflamm Bowel Dis. 2022 Feb 1;28(2):e22-e23. doi: 10.1093/ibd/izab229.

Authors

Na Wu^{1

2}, Hua Li^{1

2}, Jinyan Zhang^{1

2}, Weifeng Huang¹

Affiliations

¹ Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, China.
² The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.

PMID: 34480561
DOI: 10.1093/ibd/izab229

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Colitis, Ulcerative* / drug therapy
Crohn Disease* / drug therapy
Gastrointestinal Agents / therapeutic use
Herpes Zoster* / chemically induced
Herpes Zoster* / drug therapy
Humans

Substances

Antibodies, Monoclonal, Humanized
Gastrointestinal Agents
vedolizumab